CD276 and posterior cortical atrophy: Biopsies of these types of PCa often show expression of both membranous B7-H3 (134/141, 95.0%) and cytoplasmic B7-H3 (137/141, 97.2%), indicating that targeting these two forms of B7-H3 could significantly improve the efficacy of PCa targeted therapy [123].